Intra-Cellular Therapies Statistics
Total Valuation
SGXC:540 has a market cap or net worth of SGD 24.42 million. The enterprise value is 37.00 million.
Market Cap | 24.42M |
Enterprise Value | 37.00M |
Important Dates
The last earnings date was Monday, August 4, 2025.
Earnings Date | Aug 4, 2025 |
Ex-Dividend Date | Aug 8, 2024 |
Share Statistics
SGXC:540 has 274.40 million shares outstanding.
Current Share Class | 274.40M |
Shares Outstanding | 274.40M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +0.70% |
Owned by Insiders (%) | 6.18% |
Owned by Institutions (%) | n/a |
Float | 22.97M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.30 |
PB Ratio | 1.86 |
P/TBV Ratio | 1.81 |
P/FCF Ratio | 3.68 |
P/OCF Ratio | 3.11 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.51, with an EV/FCF ratio of 5.58.
EV / Earnings | -20.87 |
EV / Sales | 0.45 |
EV / EBITDA | 4.51 |
EV / EBIT | n/a |
EV / FCF | 5.58 |
Financial Position
The company has a current ratio of 1.10, with a Debt / Equity ratio of 2.01.
Current Ratio | 1.10 |
Quick Ratio | 0.91 |
Debt / Equity | 2.01 |
Debt / EBITDA | 3.21 |
Debt / FCF | 3.96 |
Interest Coverage | -0.76 |
Financial Efficiency
Return on equity (ROE) is -11.21% and return on invested capital (ROIC) is -1.03%.
Return on Equity (ROE) | -11.21% |
Return on Assets (ROA) | -0.76% |
Return on Invested Capital (ROIC) | -1.03% |
Return on Capital Employed (ROCE) | -1.93% |
Revenue Per Employee | 125,187 |
Profits Per Employee | -2,702 |
Employee Count | 656 |
Asset Turnover | 1.51 |
Inventory Turnover | 12.21 |
Taxes
Income Tax | -43,542 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.83% in the last 52 weeks. The beta is -0.36, so SGXC:540's price volatility has been lower than the market average.
Beta (5Y) | -0.36 |
52-Week Price Change | -25.83% |
50-Day Moving Average | 0.09 |
200-Day Moving Average | 0.11 |
Relative Strength Index (RSI) | 55.71 |
Average Volume (20 Days) | 9,660 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SGXC:540 had revenue of SGD 82.12 million and -1.77 million in losses. Loss per share was -0.01.
Revenue | 82.12M |
Gross Profit | 54.95M |
Operating Income | -661,455 |
Pretax Income | -1.66M |
Net Income | -1.77M |
EBITDA | 1.54M |
EBIT | -661,455 |
Loss Per Share | -0.01 |
Balance Sheet
The company has 13.34 million in cash and 26.30 million in debt, giving a net cash position of -12.96 million or -0.05 per share.
Cash & Cash Equivalents | 13.34M |
Total Debt | 26.30M |
Net Cash | -12.96M |
Net Cash Per Share | -0.05 |
Equity (Book Value) | 13.10M |
Book Value Per Share | 0.05 |
Working Capital | 1.92M |
Cash Flow
In the last 12 months, operating cash flow was 7.85 million and capital expenditures -1.21 million, giving a free cash flow of 6.63 million.
Operating Cash Flow | 7.85M |
Capital Expenditures | -1.21M |
Free Cash Flow | 6.63M |
FCF Per Share | 0.02 |
Margins
Gross margin is 66.91%, with operating and profit margins of -0.81% and -2.16%.
Gross Margin | 66.91% |
Operating Margin | -0.81% |
Pretax Margin | -2.02% |
Profit Margin | -2.16% |
EBITDA Margin | 1.87% |
EBIT Margin | -0.81% |
FCF Margin | 8.08% |
Dividends & Yields
This stock pays an annual dividend of 0.00, which amounts to a dividend yield of 2.55%.
Dividend Per Share | 0.00 |
Dividend Yield | 2.55% |
Dividend Growth (YoY) | -70.91% |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | 2.55% |
Earnings Yield | -7.26% |
FCF Yield | 27.16% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
SGXC:540 has an Altman Z-Score of 1.59 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.59 |
Piotroski F-Score | 3 |